相关实验视频
Updated: Jun 11, 2025

Inducible and Reversible Dominant-negative DN Protein Inhibition
Published on: January 7, 2019
一种由辅助因子诱导的抑制类型的转录因子凝聚可以通过合成来诱导,以抑制瘤发生
Yang Tang1, Fan Chen2, Gemin Fang3
1Department of Medical Ultrasound, Department of Stomatology, Shanghai Tenth People's Hospital, Tongji University Cancer Center, Tongji University School of Medicine, Shanghai, 200072, China.
像VGLL4这样的辅助因子可以诱导抑制转录因子 (TF) 凝聚物,触发细胞死亡. 模仿这种相互作用的可以通过抑制TEAD4驱动的基因转录来治疗胃癌.
科学领域:
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
- 癌症研究 癌症研究
背景情况:
- 转录因子 (TFs) 通过控制基因表达来调节细胞死亡和生存.
- TEAD4 TFs在应激细胞中形成凝结物,YAP促进激活,VGLL4等辅助因子诱导抑制.
研究的目的:
- 为了研究辅助因子在调节TEAD4凝结物功能的作用.
- 探索诱导抑制性TEAD4凝聚物的潜力,作为一种抗瘤策略.
主要方法:
- 在应力细胞中形成凝结物的TFs的识别.
- 对TEAD4-VGLL4相互作用和凝结物形成的分析.
- 设计一种来诱导TEAD4抑制凝聚.
- 在胃癌小鼠模型中评估的抗瘤作用.
主要成果:
- VGLL4和RFXANK诱导压制性TEAD4凝聚物,导致在葡萄糖饥饿期间的细胞死亡.
- TEAD4-VGLL4相互作用促进大,压抑的凝聚物纠DNA和抑制基因表达.
- 工程选择性地诱导TEAD4抑制凝聚,在胃癌模型中显示出显著的抗瘤活性.
结论:
- 共因子可以决定TF的对立功能,例如TEAD4在激活和抑制之间切换.
- 人工诱导压制性TF相分离为癌症治疗提供了一个新的策略.
- 开发的可以在胃癌中抑制TEAD4驱动的转录.
更多相关视频
10:49A Murine Cell Line Based Model of Chronic CDK9 Inhibition to Study Widespread Non-Genetic Transcriptional Elongation Defects TEdeff in Cancers
Published on: September 26, 2019
10:44In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing
Published on: May 5, 2023
相关概念视频
Co-activators and Co-repressors
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Combinatorial Gene Control
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...
Cooperative Binding of Transcription Regulators
RNA Polymerase II Accessory Proteins
General Transcription Factors